OLMA files Form 144 reporting affiliate share sales

OLMA filed a Form 144 reporting proposed and completed sales of common stock by an affiliate.

Rhea-AI Filing Summary

OLMA filed a Form 144 reporting proposed and completed sales of common stock by an affiliate. The filing lists proposed option-related sales dated 03/09/2026 (noting line items of 162,000 and 79,999 shares) and shows Shane W. Kovacs reported sales totaling 190,343 shares across dates from 01/13/2026 to 03/04/2026.

Insights

Corporate Governance Specialist

Form 144 documents affiliate share dispositions and recent open-market sales by an officer.

The filing lists proposed option-related offerings dated 03/09/2026 showing line items of 162,000 and 79,999 shares tied to issuer exercises. It also itemizes actual sales by Shane W. Kovacs totaling 190,343 shares between 01/13/2026 and 03/04/2026.

Cash proceeds per trade are shown in the excerpt; aggregate proceeds are not summed here. Subsequent filings or trade confirmations would show settlement details and any holding‑period or affiliate restrictions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does OLMA's Form 144 disclose about insider sales?

Answer: The Form 144 discloses proposed option-related sales dated 03/09/2026 and multiple completed sales by Shane W. Kovacs totaling 190,343 shares from 01/13/2026 to 03/04/2026. The filing lists per-trade cash proceeds alongside each sale.

Who is the selling party named in OLMA's Form 144?

Answer: The excerpt names Shane W. Kovacs with an address in San Francisco and shows multiple sales. It also lists a broker, Fidelity Brokerage Services LLC, in the securities-to-be-sold section dated 03/09/2026.

How many shares were reported sold by Shane W. Kovacs in the past three months?

Answer: The filing's trade lines sum to 190,343 shares sold between 01/13/2026 and 03/04/2026. Individual trade sizes and cash proceeds are listed per date in the excerpt.

Are the proposed sales tied to option exercises in the OLMA Form 144?

Answer: The securities-to-be-sold section references option grants with grant dates 02/01/2022 and 02/28/2025 and shows line items of 162,000 and 79,999 shares dated 03/09/2026, indicating option-related sales are reported.

Does OLMA's Form 144 show cash proceeds for each sale?

Answer: Yes. Each sale line for Shane W. Kovacs includes a cash proceeds figure (for example, $2,873,214.99 for 01/15/2026). The excerpt presents per-trade proceeds alongside share amounts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/09/2026 - 03:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001579397
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Olema Pharmaceuticals, Inc.
SEC File Number	001-39712
Address of Issuer	780 BRANNAN STREET SAN FRANCISCO CALIFORNIA 94103
Phone	(415) 651-3316
Name of Person for Whose Account the Securities are To Be Sold	Kovacs Shane William Charles
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	241999	3254933.05	68659923	03/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/09/2026	Option Granted 02/01/2022	Issuer			162000	03/09/2026	Cash
Common	03/09/2026	Option Granted 02/28/2025	Issuer			79999	03/09/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	01/13/2026	3822	107069.20
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	01/15/2026	100000	2873214.99
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/12/2026	10000	238498.19
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/23/2026	30000	723007.46
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/24/2026	20000	500002.00
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	02/27/2026	6521	163026.25
Shane W. Kovacs 780 Brannan Street San Francisco CA 94103	Common	03/04/2026	20000	488653.67

144: Remarks and Signature

Remarks
Date of Notice	03/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Joshua Schmitt, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Shane W. Kovacs.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)